Literature DB >> 28255748

Tumor types, breast tumor subtypes and extension of systemic disease may influence outcome in cancer patients with brain metastases.

Kadri Altundag1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28255748     DOI： 10.1007/s11060-017-2402-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  2 in total

1.  Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.

Authors:  Kirtesh R Patel; Stuart H Burri; Danielle Boselli; James T Symanowski; Anthony L Asher; Ashley Sumrall; Robert W Fraser; Robert H Press; Jim Zhong; Richard J Cassidy; Jeffrey J Olson; Walter J Curran; Hui-Kuo G Shu; Ian R Crocker; Roshan S Prabhu
Journal:  J Neurooncol       Date:  2016-12-20       Impact factor: 4.130

2.  Breast cancer brain metastases - A 12 year review of treatment outcomes.

Authors:  P B De Ieso; U Schick; N Rosenfelder; K Mohammed; G M Ross
Journal:  Breast       Date:  2015-04-13       Impact factor: 4.380
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.